Prenatal diagnosis of fetal trisomies is usually performed by cytogenetic analysis on amniotic fluid. This requires lengthy laboratory procedures and high costs, and is unsuitable for large scale screening of pregnant women. An alternative method, which is both rapid and inexpensive and suitable for diagnosing trisomies even from single fetal cells, is the fluorescent polymerase chain reaction using polymorphic small tandem repeats (STRs). In this paper we present the preliminary results of a larger study comparing parallel prenatal diagnoses of trisomies 21 and 18 using cytogenetics with quantitative fluorescent polymerase chain reaction using STR markers. The results obtained by the two techniques were concordant in all cases. This is the first study reporting significant numbers of prenatal diagnoses using the quantitative fluorescent polymerase chain reaction. We believe that further studies on greater numbers of samples will determine the absolute reliability ofthis technique. These results also provide a model for diagnosis of trisomy from single fetal cells isolated from maternal blood.
Chromosomal abnormalities are the most frequent genetic disorders observed in both live births and miscarriages. Trisomies, the largest group, accounts for -53% of all chromosome abnormalities in early fetal deaths, directly result in 17% of all fetal deaths, and are therefore a major cause of spontaneous abortion.'
The most common single trisomies are 22, 21, 16, 13, 2, and 18, of which only 21 severe mental retardation, high risk of congenital heart disease, and other multiple malformations and is the major reason that older mothers seek prenatal diagnosis. The next most common trisomy observed in prenatal diagnosis is trisomy 18 (Edwards syndrome). Even though -90% of trisomy 18 pregnancies result in fetal death, this syndrome has an incidence of 1 affected newborn in 1000 live births and results in severe mental retardation, multiple malformations, and is generally fatal before 1 year of age.
As the frequency of chromosomal abnor- (fig 2) samples showed a characteristic diallelic pattern with a fluorescent intensity ratio of 2:1.
Although ratio ranges of normal heterozygous and diallelic trisomic samples did not overlap, diallelic trisomic samples should be investigated further using other markers on each chromosome to determine the quantitative amplification of different alleles and thus the trisomy. The method is based on the observation thai the amount of PCR products is proportional tc the quantity of initial target sequence. The firsi report using quantitative fluorescent PCR tc examine trisomies dates from 1993'; however this method has been used for prenatal diagnosis by only a few groups." 10 11 We report our initial experiences using quantitative fluorescent PCR for prenata exclusion of trisomy 21 and 18. These preliminary experiments show that fluorescent PCR amplification of STRs can reliably be used for the detection of trisomies of both chromosomes 21 and 18. Allelic drop out, as described by Findlay et al,'2 was not observed during the PCRs (table 2, relative peak areasrange). However, to minimise the chance of misdiagnosis, the PCRs were repeated. The introduction of additional markers is also recommended and this is currently under investigation in our laboratory. STR markers on other chromosomes could also be used in a similar manner allowing detection of other chromosomal abnormalities by molecular genetic methods rather than cytogenetic analysis.
We believe that using two highly polymorphic STR markers on each chromosome would allow diagnostic accuracy to be increased in most of the cases investigated. In noninformative cases further polymorphic marker(s) could be amplified. We are currently using a multiplex PCR assay with several STR markers for chromosomes 21, 18, and 13 which will allow this technique to become even more valuable in the prenatal detection of trisomies. Quantitative fluorescent PCR was used in parallel with cytogenetic analysis for prenatal detection of trisomies as a "back up" in case of culture or cytogenetic analysis failure.
This technique allows detection of trisomies within four hours in urgent cases, allowing amniocentesis and possible termination to be undertaken on the same day. This is especially important when the pregnancy is relatively advanced as delay may lead to gestation exceeding the legal limit for termination.
Amniocentesis takes about 10 minutes and DNA preparation from amniotic fluid takes only 50 minutes using the DNA purification system (Promega, USA) instead of a long phenol/chloroform extraction procedure. 
